69É«ÇéƬ

Medicine never stands still; so neither can underwriting. For accurate, best-in-class risk calculation, the industry needs precise, flexible, and convenient solutions.

69É«ÇéƬ has harnessed its global research and data science capabilities and partnered with clients ... Read More

Curious about 69É«ÇéƬ's data science insights?  Contact us to le...

Read More

The novel coronavirus has forced many of us to confront our own vulnerability to loss and to think more seriously about planning for our family’s protection, according to 69É«ÇéƬ's Dr. Dave Rengachary. He calls on the industry to consider how to make insurance products more... Read More

The global effort to develop mRNA-based vaccines for COVID-19 has greatly advanced mRNA technology and increased the speed of mRNA vaccine development, and it is likely that new mRNA vaccines for other diseases will soon emerge. Read More

Challenges have a way of driving change. 69É«ÇéƬ's Naohiro Iwamoto looks back at the pandemic year of 2020 and surveys the many ways COVID-19 has accelerated change throughout the insurance industry and beyond.

Read More

Could anxiety and uncertainty fuelled by an ongoing pandemic lead to a mental health crisis? 69É«ÇéƬ's Enrique Ruiz, Managing Director of Spain and Portugal, explores this question in

Read More

The global burden of gestational diabetes mellitus (GDM) is on the rise alongside increases in obesity and changing lifestyles. In ReFlections, 69É«ÇéƬ's Dr. Reema Nathwani Jani explores the history, complications, management, and long-term outcomes of GDM on ma...

Read More

Underwriting pulmonary and thyroid nodules has always been a distinct challenge. In a two-part article for ReFlections, 69É«ÇéƬ's Sandeepan Basu seeks to simplify the underwriting challenges associated with both types of nodules by identifying factors to ... Read More

Rapid advances in medical science’s understanding of the human genome have led to the recent development of novel gene-based therapeutic strategies. In ReFlections, 69É«ÇéƬ's Dr.Dan Zimmerman defines gene and cell therapies and provides insights into these rapid...

Read More

Insurance-linked wellness reward programs can too often fail to pay for themselves, and data from wearable devices is not yet widely or confidently used in underwriting risk assessment. 69É«ÇéƬ's Raajeev Bhayana explores the relationships between wearable data and health...

Read More

In this issue, explore topics from demystifying pulmonary and thyroid nodules to current trends in gestational diabetes and gene therapy. 
Read More

Long before the current pandemic, vaccines have proven to be historical game-changers in the prevention of infectious diseases. 69É«ÇéƬ sat down with Senior Vice President and Head of Global Medical Dr. Daniel Zimmerman and Global Medical Researcher Hilary Henly to discuss ... Read More

After a torrid compound annual growth rate of 43% since 2013, the Middle East health insurance market is experiencing growing pains, including challenges to sustainability and profitability. A new survey from 69É«ÇéƬ identifies causes and solutions.

Read More

Read More

Curious about 69É«ÇéƬ's medical insights?  Contact us to learn m...

Read More

Read More

The freelance – or gig – economy is booming, but the flexibility of job-to-job work can come at a cost; the self-employed are increasingly underinsured and financially insecure. 69É«ÇéƬ's Diana Bosworth explains how an array of incumbent insurers and new insurtech entrants ... Read More

What if technology and behavioral science could work together to help all of us live healthier, longer lives? The impact could be transformative, argues Emmanuel Djengue of 69É«ÇéƬX and Eric Gaubert of 69É«ÇéƬ France. Read More

For 69É«ÇéƬ's Ron Herrmann, COVID-19 demonstrated, as nothing else could, the importance of what carriers do to protect lives and livelihoods. He calls on the industry to band together to raise awareness about the value of life insurance and address America’s steadily ... Read More

When faced with operational challenges most organizations will demonstrate a bias towards new technologies. The past year’s COVID-19 pandemic is showing that finding ways to increase adoption of existing solutions may be just as, if not more, effective in influencing co... Read More